Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.51 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | F2R | P25116 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10740204 | 0.86 | CYP1A2 (0.57) | CYP1A2ALDH1A1KDM4EGAAPFKFB3 | |
| SCHEMBL10974039 | 0.80 | CYP1A2 (0.49) | CYP1A2ALDH1A1KDM4EGAAPFKFB3 | |
| SCHEMBL28621619 | 0.78 | CCR1 (0.50) | ALDH1A1KDM4ECCR1CYP2A6KMT2A | |
| SCHEMBL28280669 | 0.77 | KDM4E (0.51) | CYP1A2ALDH1A1KDM4EGAACCR1 | |
| SCHEMBL2169969 | 0.76 | CCR1 (0.48) | CYP1A2ALDH1A1KDM4ECCR1CYP2A6 | |
| SCHEMBL18572379 | 0.76 | CCR1 (0.48) | CYP1A2ALDH1A1KDM4EGAAPFKFB3 | |
| SCHEMBL29954808 | 0.76 | CCR1 (0.48) | CYP1A2ALDH1A1KDM4EGAAPFKFB3 | |
| SCHEMBL3748357 | 0.76 | CCR1 (0.48) | ALDH1A1KDM4ECCR1KMT2ANPSR1 | |
| SCHEMBL2016701 | 0.76 | BACE1 (0.52) | CYP1A2ALDH1A1KDM4ECCR1CYP2A6 | |
| SCHEMBL2672759 | 0.76 | TERT (0.60) | ALDH1A1KDM4EGAACCR1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10010542-B2 | PFKFB3 inhibit and methods of use as an anti-cancer therapeutic | GB ACT, INC. (US) | 2018-07-03 | — | — | US | disclosed |
| US-20170258783-A1 | PFKFB3 INHIBIT AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC | GB005, INC. | 2017-09-14 | — | — | US | disclosed |
| US-9649305-B2 | PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic | ADVANCED CANCER THERAPEUTICS, LLC (US) | 2017-05-16 | — | — | US | disclosed |
| US-20150064175-A1 | PFKFB3 INHIBITOR AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC | GB005, INC. | 2015-03-05 | — | — | US | disclosed |
| US-8071620-B2 | Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors | TOPOTARGET UK LIMITED (GB) | 2011-12-06 | — | — | US | disclosed |
| US-20100093743-A1 | CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS | TOPOTARGET UK LIMITED (GB) | 2010-04-15 | — | — | US | disclosed |
| US-7652036-B2 | Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors | TOPOTARGET UK LIMITED (GB) | 2010-01-26 | — | — | US | disclosed |
| US-20060079528-A1 | (E)-3-(1,3-Benzoxazol-2-yl)-N-hydroxy-2-propenamide; Methyl (E)-3-(2-quinolinyl)-2-propenoate; histone deacetylase inhibitors; inflammatory disease; cancer | TOPOTARGET UK LIMITED (GB) | 2006-04-13 | — | — | US | disclosed |
| EP-1599449-A2 | CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS | TopoTarget UK Limited (GB) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004076386-A2 | CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS | TOPOTARGET UK LIMITED (GB) | 2004-09-10 | — | — | WO | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258783-A1 | PFKFB3 INHIBIT AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC | PFKFB3, PFKFB1, PFKFB2 | CYP1A2 2493/4885ALDH1A1 1250/4885KDM4E 708/4885 |
| US-20060079528-A1 | (E)-3-(1,3-Benzoxazol-2-yl)-N-hydroxy-2-propenamide; Methyl (E)-3-(2-quinolinyl)-2-propenoate; histone deacetylase inhibitors; inflammatory disease; cancer | HDAC1, HDAC11, HDAC5 | CYP1A2 2188/4885ALDH1A1 1467/4885KDM4E 35/4885 |
| US-10010542-B2 | PFKFB3 inhibit and methods of use as an anti-cancer therapeutic | PFKFB3, PFKFB1, PFKFB2 | CYP1A2 2493/4885ALDH1A1 1250/4885KDM4E 708/4885 |
| US-20150064175-A1 | PFKFB3 INHIBITOR AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC | PFKFB3, PFKFB1, PFKFB2 | CYP1A2 2362/4885ALDH1A1 1310/4885KDM4E 710/4885 |
| US-20100093743-A1 | CARBAMIC ACID COMPOUNDS COMPRISING A BICYCLIC HETEROARYL GROUP AS HDAC INHIBITORS | HDAC1, HDAC7, HDAC5 | CYP1A2 1355/4885ALDH1A1 1740/4885KDM4E 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.